Vyant Bio, Inc. Reports Net Loss of $22.7 Million in 2022

Vyant Bio, Inc.(VYNT), a biotechnology compan y, released its consolidated financial statements for the year ended December 31, 2022. The report revealed a net loss of $22.7 million, significantly impacting its financial position. Additionally, the company's revenue declined to $666 thousand in 2022. Let's delve deeper into Vyant Bio's financial performance and the factors contributing to these figures.

Vyant Bio, Inc. Reports Net Loss of $22.7 Million in 2022

Vyant Bio, Inc. faced significant financial challenges in 2022, as evident from its consolidated statements of operations and comprehensive loss. The company reported a net loss of $22.7 million for the year, compared to a net loss of $40.9 million in the previous year (2021). This net loss indicates a reduction in the company's profitability, raising concerns among investors and stakeholders.

Revenue for Vyant Bio, Inc. Declines to $666 Thousand in 2022